1. Home
  2. ABEO vs RFMZ Comparison

ABEO vs RFMZ Comparison

Compare ABEO & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$2.37

Market Cap

282.5M

Sector

Health Care

ML Signal

N/A

Logo RiverNorth Flexible Municipal Income Fund II Inc.

RFMZ

RiverNorth Flexible Municipal Income Fund II Inc.

N/A

Current Price

$12.00

Market Cap

290.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ABEO
RFMZ
Founded
1974
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
282.5M
290.5M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ABEO
RFMZ
Price
$2.37
$12.00
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $18.38
N/A
AVG Volume (30 Days)
★ 1.7M
88.8K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 165.16
N/A
EPS
N/A
★ N/A
Revenue
★ $2,998,000.00
N/A
Revenue This Year
$731.38
N/A
Revenue Next Year
$129.85
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.18
N/A
52 Week Low
$2.30
$11.31
52 Week High
$7.65
$13.70

Technical Indicators

Market Signals
Indicator
ABEO
RFMZ
Relative Strength Index (RSI) 17.47 50.43
Support Level N/A $11.84
Resistance Level $5.77 $12.19
Average True Range (ATR) 0.30 0.18
MACD -0.19 0.03
Stochastic Oscillator 2.67 44.32

Price Performance

Historical Comparison
ABEO
RFMZ

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.

RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: